DxTerity Earns SOC 2 Type 2 Compliance, Reinforcing Commitment to Secure Healthcare Data. Read more
  {modal url="index.php?option=com_content&view=category&layout=blog&id=18&Itemid=125" class="modalsign"}{/modal}

What makes DxTerity different

 

 

bringing precision

Bringing precision medicine
to autoimmune disease

DxTerity is pioneering the use of RNA based Immune System Profiling to better understand the root causes of autoimmune conditions. RNA testing is very different than DNA testing. RNA changes with you and your environment, providing a more complete picture of your disease status.

Learn more

line1

bringing precision

Patient centric

Better health management begins at home, and it begins with you. We are empowering patients with powerful new tools for managing their health. Take charge of your care.

Learn more

 

line2

bringing precision

High tech, low cost

We believe that our diagnostic tests must also be affordable. Our underlying, patented technologies enable cost-effective delivery of cutting-edge precision medicine.

Learn more

 

 

 

 

 

 

 

 
image65


Our community
needs your help

Over the past 12 years, DxTerity has demonstrated a positive track record of providing patients access to cutting-edge RNA tests that accelerate discoveries in autoimmune disease prognosis and treatment.

Clinical studies like ELEVATE can provide much needed real-world evidence to help providers and payers see the value of RNA testing in SLE, paving the way for the development of new treatments to improve patients quality of life.

Learn more

Sign up for our ELEVATE Clinical Study today

 

Path1

0M

Americans

affected by autoimmune related diseases

Path2

0%

Women

3 quarters of people with autoimmune disease are women

Path3

0+

Medicines

in development to treat autoimmune diseases

Path4

0B+

Healthcare burden

30-50% autoimmune patients go undiagnosed or misdiagnosed

 

 

What people are saying

 

people

Better health management begins
at home

Subscribe to receive the latest information on new developments and products at DxTerity.